News 21.09.2021 Schlieren-Zurich, Switzerland, September 21, 2021. Proteomedix, the Swiss cancer diagnostics company has entered into a research and development partnership with New Horizon Health Limited (6606.SEHK). To support the joint program New Horizon Health has invested CHF 3.0 million in a convertible loan in Proteomedix. The partnership builds on complimentary platform...
Events, External events
Event date: 30.09.2021
3:00 – 4:00 PM (CEST)
During this live event, we will discuss:
- Different sample types
- Proper sample collection for RNA extraction
- Storage and shipping
- Extraction methods
- Quality criteria
- Downstream services and their requirements
As a takeaway we are happy to share a short list of Do’s and Dont’s.
Of course, we will have...
News 16.09.2021 SCHLIEREN, ZURICH, September 16, 2021 — Anjarium Biosciences AG (“Anjarium”), a biotech company focused on creating and delivering a new class of non-viral gene therapies today announced the closing of a CHF55.5M ($61M) Series A financing. The round was co-led by Abingworth and Gimv, with significant participation from Omega Funds,...
News 09.09.2021 Schlieren (Zurich), Switzerland, 9 September, 2021 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for MagnetOs Easypack Putty, a soft and moldable formulation ideal for packing into...
Events, Internal events
Event date: 21.09.2021
Gastronomie Wagi-S at Wagistrasse 12
Discover how CSEM can support Life Sciences companies to innovate
Innovation in the field of Life Sciences increasingly requires multi-disciplinary competences – at the convergence between technology and biology. CSEM’s technology platforms address the evolving needs of the life science domain by utilizing the latest advancements in...